Moderate to Severe Glabellar Frown Lines
3 clinical trials · Condition
◉ Watch Moderate to Severe Glabellar Frown Lines
| Record | Firm | Date |
|---|---|---|
| Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines (NCT03806933) | Merz Aesthetics GmbH | 2019-01-23 |
| IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2 (NCT00770029) | Merz Pharmaceuticals GmbH | 2008-10-01 |
| IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines (NCT00770211) | Merz Pharmaceuticals GmbH | 2008-10-01 |
Track Moderate to Severe Glabellar Frown Lines automatically
Every clearance here is in the API, with alerts when new ones post.